State of Wisconsin Investment Board
NKTR icon

State of Wisconsin Investment Board’s Nektar Therapeutics NKTR Stock Holding History

State of Wisconsin Investment Board’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$984K Buy
13,670
+5,041
+58% +$287K ﹤0.01% 1699
2025
Q4 		$365K Buy
+8,629
New +$483K ﹤0.01% 2088
2023
Q2 		– Sell
-1,584
Closed -$16.7K – 2466
2023
Q1 		$16.7K Sell
1,584
-10,182
-87% -$308K ﹤0.01% 2500
2022
Q4 		$399K Sell
11,766
-755
-6% -$36.5K ﹤0.01% 1989
2022
Q3 		$601K Sell
12,521
-654
-5% -$38.9K ﹤0.01% 1876
2022
Q2 		$751K Buy
13,175
+2,092
+19% +$132K ﹤0.01% 1828
2022
Q1 		$896K Buy
11,083
+9,615
+655% +$1.42M ﹤0.01% 1662
2021
Q4 		$297K Sell
1,468
-15
-1% -$3.25K ﹤0.01% 1964
2021
Q3 		$399K Buy
1,483
+70
+5% +$16.8K ﹤0.01% 1750
2021
Q2 		$364K Sell
1,413
-52
-4% -$14.4K ﹤0.01% 1799
2021
Q1 		$440K Sell
1,465
-21
-1% -$6.54K ﹤0.01% 1633
2020
Q4 		$379K Sell
1,486
-63
-4% -$16.3K ﹤0.01% 1616
2020
Q3 		$385K Buy
1,549
+30
+2% +$9.44K ﹤0.01% 1567
2020
Q2 		$528K Sell
1,519
-7,704
-84% -$2.4M ﹤0.01% 1414
2020
Q1 		$2.47M Sell
9,223
-80
-0.9% -$24.7K 0.01% 1010
2019
Q4 		$3.01M Sell
9,303
-3,988
-30% -$1.16M 0.01% 1064
2019
Q3 		$3.63M Buy
13,291
+844
+7% +$310K 0.01% 893
2019
Q2 		$6.64M Buy
12,447
+4,670
+60% +$2.34M 0.02% 745
2019
Q1 		$3.92M Sell
7,777
-8,130
-51% -$4.82M 0.01% 868
2018
Q4 		$7.84M Buy
15,907
+1,103
+7% +$666K 0.03% 630
2018
Q3 		$13.5M Buy
14,804
+4,813
+48% +$4.11M 0.04% 497
2018
Q2 		$7.32M Sell
9,991
-476
-5% -$549K 0.02% 769
2018
Q1 		$16.7M Buy
10,467
+667
+7% +$859K 0.05% 410
2017
Q4 		$8.78M Buy
9,800
+2,133
+28% +$1.26M 0.02% 687
2017
Q3 		$2.76M Hold
7,667
– – 0.01% 936
2017
Q2 		$2.25M Buy
+7,667
New +$2.22M 0.01% 932

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State of Wisconsin Investment Board's NKTR Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Nektar Therapeutics (NKTR) stake by 58% in Q1 2026, buying an estimated $287K and bringing the position to 13,670 shares worth $984K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

State of Wisconsin Investment Board first reported a position in NKTR in Q2 2017 and has held it in 26 quarters since. The position peaked at $16.7M in Q1 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • State of Wisconsin Investment Board held 13,670 shares of Nektar Therapeutics worth $984K as of Q1 2026.
  • State of Wisconsin Investment Board bought 5,041 Nektar Therapeutics shares in Q1 2026, an estimated $287K.
  • Nektar Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1699 holding.
  • State of Wisconsin Investment Board first reported a position in Nektar Therapeutics in Q2 2017 and has held it in 26 quarters since.
  • State of Wisconsin Investment Board's Nektar Therapeutics position peaked at $16.7M in Q1 2018.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.